Herve Affagard

Company: Maat Pharma

Job title: Founder & Chief Executive Officer

Seminars:

Panel Discussion: Defining Innovative Clinical Strategies Conserving Spend 9:00 am

Join panelists to address securing funding strategies and perspectives on: What adaptive trial methodologies or other innovative approaches can biopharma look to incorporate for cost-efficiency which also guarantee rigor? What are the benefits and drawbacks of strategic partnerships as an approach to expertise sharing and accelerated progress in microbiome drug development? What criteria and benchmarks…Read more

day: Conference Day Two

Advancing a Non-Infectious Disease Indication Through Clinical Development 3:30 pm

Explore a clinical case study demonstrating how microbiome drug development is progressing for diseases beyond infectious Key milestones and challenges encountered to underscore efficacy demonstration in non-infectious targets Uncover patient outcomes and clinical markers demonstrating the therapeutic impact of microbiome modulation in a novel therapeutic contextRead more

day: Conference Day One

Workshop D – Microbiome Macroeconomics: Analysing Industry Trends to Inform Microbiome Drug Development Strategy 4:00 pm

With industry trends serving as crucial guideposts for strategic decision-making in microbiome drug development, seize the opportunity in this workshop to benchmark effective practices and explore: Trend-Informed Pipeline Strategy Beyond Drug Development: Examine the latest industry trends shaping microbiome drug development, as well as across the microbiome product field, and how these inform strategic decisions…Read more

day: Workshop Track 4